Refractory heart failure dependent on short-term mechanical circulatory support: What next? Heart transplant or long-term ventricular assist device

Artificial Organs

Volumn 38, Issue 4, 2014, Pages 276-281

  Mohite, Prashant N ^a   Zych, Bartlomiej ^a   Banner, Nicholas R ^a   Simon, Andre R ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

End stage heart failure; Heart transplantation; Ventricular assist device

Indexed keywords

DISEASES; FIBER OPTIC SENSORS; HEART; LEFT VENTRICULAR ASSIST DEVICES; PATIENT REHABILITATION; PATIENT TREATMENT; REFRACTORY MATERIALS;

CHRONIC HEART FAILURES; CIRCULATORY SUPPORT; END-STAGE HEART FAILURE; HEART FAILURE; HEART TRANSPLANT; HEART TRANSPLANTATION; MECHANICAL CIRCULATORY SUPPORT; MEDICAL TREATMENT; ORGAN FAILURE; VENTRICULAR ASSIST DEVICE;

CARDIOLOGY;

ACUTE HEART FAILURE; ASSISTED CIRCULATION; BACTERIAL INFECTION; GRAFT FAILURE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; HEART ASSIST DEVICE; TREATMENT OUTCOME;

HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; TREATMENT OUTCOME;

EID: 84897572232     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12157     Document Type: Review

References (37)

1. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433.
2. Lloyd-Jones D, Adams RJ, Brown TM etal.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:346-e215.
3. Townsend N, Wickramasinghe K, Bhatnagar P, et al. Coronary heart disease statistics 2012 edition. London: British Heart Foundation, 2012.
4. Stevenson LW, Miller LW, Desvigne-Nickens P, et al.; REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004;110:975-981.
5. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1, 000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10.
6. Yoshioka D, Sakaguchi T, Saito S, et al. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. Circ J 2012;76:1631-1638.
7. González A, Adsuar A, Hernández A, et al. Is an emergency heart transplantation justified? Transplant Proc 2006;38:2531-2533.
8. Barge-Caballero E, Paniagua-Martín MJ, Marzoa-Rivas R, et al. Usefulness of the INTERMACS scale for predicting outcomes after urgent heart transplantation. Rev Esp Cardiol 2011;64:193-200.
9. Agüero J, Zarragoikoetxea I, Almenar L, et al. Differences in early postoperative complications in elective and emergency heart transplantation. Transplant Proc 2008;40:3041-3043.
10. Pal JD, Piacentino V, Cuevas AD, et al. Impact of left ventricular assist device bridging on posttransplant outcomes. Ann Thorac Surg 2009;88:1457-1461; discussion 1461.
11. Hong KN, Iribarne A, Worku B, et al. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg 2011;92:520-527.
12. Samuels LE, Holmes EC, Thomas MP, et al. Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg 2001;71:S67-72; discussion S82-5.
13. Lad V, Elhenawy A, Harwood S, et al. Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience. Can J Cardiol 2010;26:467-470.
14. Beiras-Fernandez A, Deutsch MA, Kainzinger S, et al. Extracorporeal membrane oxygenation in 108 patients with low cardiac output-a single-center experience. Int J Artif Organs 2011;34:365-373.
15. Kumar TK, Zurakowski D, Dalton H, et al. Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. J Thorac Cardiovasc Surg 2010;140:330-336.e2.
16. Meyns B, Simon A, Klotz S, et al. Clinical benefits of partial circulatory support in New York Heart Association Class IIIb and Early Class IV patients. Eur J Cardiothorac Surg 2011;39:693-698.
17. Meyns B, Klotz S, Simon A, et al. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol 2009;54:79-86.
18. Griffith BP, Anderson MB, Samuels LE, Pae WE Jr, Naka Y, Frazier OH. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg 2013;145:548-554.
19. Manzo-Silberman S, Fichet J, Mathonnet A, et al. Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and IMPELLA Recover LP2.5. Resuscitation 2013;84:609-615.
20. Kar B, Adkins LE, Civitello AB, et al. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J 2006;33:111-115.
21. Gregoric ID, Jacob LP, La Francesca S, et al. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J 2008;35:125-129.
22. Popov AF, Hosseini MT, Zych B, et al. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 2012;93:810-815.
23. Birks EJ, Yacoub MH, Banner NR, Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol 2004;19:148-153.
24. Backes D, van den Bergh WM, van Duijn AL, Lahpor JR, van Dijk D, Slooter AJ. Cerebrovascular complications of left ventricular assist devices. Eur J Cardiothorac Surg 2012;42(4):612-620.
25. John R, Lee S, Eckman P, Liao K. Right ventricular failure-a continuing problem in patients with left ventricular assist device support. J Cardiovasc Transl Res 2010;3:604-611.
26. John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010;140:174-181.
27. McKenna DH Jr, Eastlund T, Segall M, Noreen HJ, Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant 2002;21:1218-1224.
28. Arnaoutakis GJ, George TJ, Kilic A, et al. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. J Thorac Cardiovasc Surg 2011;142:1236-1245, 1245.
29. Acharya MN, Som R, Tsui S. What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device? Interact Cardiovasc Thorac Surg 2012;14:209-214.
30. Pak SW, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010;29:1172-1176.
31. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
32. Strueber M, O'Driscoll G, Jansz P, etal. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011;57:1375-1382.
33. Urban M, Pirk J, Dorazilova Z, Netuka I. How does successful bridging with ventricular assist device affect cardiac transplantation outcome? Interact Cardiovasc Thorac Surg 2011;13:405-409.
34. US Department of Health and Human Services. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation.
35. Barbone A, Malvindi PG, Sorabella RA, et al. 6 months of "temporary" support by Levitronix left ventricular assist device. Artif Organs 2012;36:639-642.
36. Griffith KE, Jenkins E, Stulak J, Paugh T, Pagani FD. Long-term use of the CentriMag Ventricular Assist System as a right ventricular assist device: a case report. Perfusion 2012;27:65-70.
37. Mohite PN, Zych B, Popov AF, Krueger H, Banner NR, Simon AR. Use of Levitronix CentriMag as a bridge to solution beyond 30 days-is it safe? J Heart Lung Transplant 2012;31(4s):s186.